DGAM
NVO

Desjardins Global Asset Management’s Novo Nordisk NVO Stock Holding History

Desjardins Global Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$29.1K Buy
281
+8
+3% +$791 ﹤0.01% 572
2023
Q3 		$24.8K Sell
273
-31
-10% -$2.73K ﹤0.01% 593
2023
Q2 		$24.6K Sell
304
-66
-18% -$5.39K ﹤0.01% 558
2023
Q1 		$29K Buy
370
+2
+0.5% +$142 ﹤0.01% 552
2022
Q4 		$24K Buy
+368
New +$21.6K ﹤0.01% 463

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Desjardins Global Asset Management's NVO Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Novo Nordisk (NVO) stake by 2.9% in Q4 2023, buying an estimated $791 and bringing the position to 281 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

Desjardins Global Asset Management first reported a position in NVO in Q4 2022 and has held it in 5 quarters since. 1,511 funds tracked by Wall St. Rank hold NVO as of Q4 2023.

  • Desjardins Global Asset Management held 281 shares of Novo Nordisk worth $29.1K as of Q4 2023.
  • Desjardins Global Asset Management bought 8 Novo Nordisk shares in Q4 2023, an estimated $791.
  • Novo Nordisk made up ﹤0.01% of Desjardins Global Asset Management's portfolio in Q4 2023, its #572 holding.
  • Desjardins Global Asset Management first reported a position in Novo Nordisk in Q4 2022 and has held it in 5 quarters since.
  • 1,511 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.